PEDIATRICS Vol. 97 No. 5 May 1996, pp. 699
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

AID$

. . . AIDS has become a multi-billion dollar growth industry, offering scientists a chance to make their name and drug companies and entrepreneurs an opportunity to make a fortune. This is more than simply a matter of competing for the millions of dollars the federal government annually spends for AIDS research; it's also about scientific reports bolstering the stock prices of multinational drug companies, an expanding job market for bereavement counselors and benefits coordinators, and the proliferation of new businesses catering to the needs of the ill and the fears of the healthy.

Condom makers, mail-order drug companies, home health care services, vitamin, and health food stores have all benefited from the AIDS epidemic.